Search

everythinglearnresearchcommunity

for

Search:↓

Topical treatment SM04554 safely promotes hair growth in male baldness.

New nonsteroidal molecules can potentially increase dihydrotestosterone in neurons by blocking certain enzymes, without affecting prostate and seminal vesicle weight.

Using anabolic-androgenic steroids can cause skin problems like acne and hair loss in athletes.

PSA could be a marker for hyperandrogenism in women, but more research is needed.

20% of patients with androgenic alopecia also had metabolic syndrome.

Targeting Sirt1 can reduce androgen levels and slow glioblastoma growth.

Androgen receptors significantly affect hair loss in women with androgenetic alopecia.

Genetic profiling can improve androgenetic alopecia treatment by predicting drug response and minimizing side effects.

Weekly treatments increased hair density in men with androgenetic alopecia.

Men with early-onset hair loss have less cardiometabolic benefit from bromocriptine.

Androgenetic alopecia in men is genetic and linked to health issues like obesity and heart disease, with treatments including minoxidil, finasteride, and hair transplants.

Insulin resistance may contribute to hair loss in people with androgenic alopecia.

Taurine may help reduce hair loss by improving hair growth cycles.

A 15-year-old girl with no menstrual period was diagnosed with a genetic condition that makes her body unable to respond to male hormones, leading to female characteristics despite having male genetic makeup.

Hormonal differences affect male pattern baldness.

The document's conclusion cannot be provided because the content is not available.

Current treatments can slow hair loss and promote regrowth, with hair transplantation being most effective for advanced cases.

Current treatments can slow hair loss and promote regrowth, with hair transplantation being most effective for advanced cases.

Patients with early-onset androgenetic alopecia have a higher risk of metabolic syndrome and carotid arteriosclerosis, suggesting the need for early cardiovascular screening and prevention.

Pediatric androgenetic alopecia is linked to obesity, family history, hormonal imbalances, and requires personalized treatment including managing comorbidities.

A short male anogenital distance may indicate incomplete masculinization due to disrupted androgen action.

Confirm testosterone levels with advanced tests to avoid unnecessary procedures.

Scientists created iodinated arylhydantoins and arylthiohydantoins that could potentially be used for imaging prostate cancer. Some versions with specific side-chains showed high potential for this use.

Genomic approach finds new possible treatments for hair loss.

Androgenetic alopecia is common hair loss due to genetics and DHT.

Athletes use steroids to enhance performance despite health risks and legal issues, and education on their dangers is needed.

High aldosterone and free testosterone levels link to female hair loss; testing aldosterone may predict hypertension risk.

Older men with high total testosterone might not show symptoms, while younger men with hyperandrogenism may experience hair loss or acne.